Compare CHT & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHT | ALC |
|---|---|---|
| Founded | 1996 | 1945 |
| Country | Taiwan | Switzerland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Ophthalmic Goods |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9B | 32.4B |
| IPO Year | 2003 | 2002 |
| Metric | CHT | ALC |
|---|---|---|
| Price | $46.08 | $66.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $89.38 |
| AVG Volume (30 Days) | 111.6K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.02% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.37 | $7.99 |
| Revenue Next Year | $3.23 | $6.38 |
| P/E Ratio | ★ $26.66 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.28 | $61.84 |
| 52 Week High | $47.03 | $92.55 |
| Indicator | CHT | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 65.36 | 47.41 |
| Support Level | $41.79 | $64.01 |
| Resistance Level | N/A | $68.48 |
| Average True Range (ATR) | 0.59 | 1.06 |
| MACD | 0.14 | 0.48 |
| Stochastic Oscillator | 95.32 | 62.42 |
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.